legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

# Capsida Biotherapeutics to Present Corporate Update at Investor and Industry Conferences

## Thousand Oaks, Calif., Sept. 20, 2023 /PRNewswire/ —

Capsida Biotherapeutics (“Capsida”), a leading gene therapy company, has announced that Peter Anastasiou, the Chief Executive Officer, will present a corporate update at two important upcoming conferences. These conferences provide valuable opportunities for investors and industry professionals to gain insights into the latest developments and progress at Capsida.

## Important Dates and Locations

1. Jefferies Cell & Genetic Medicine Summit:

– Date: Wednesday, September 27, 2023
– Time: 9:30 AM ET
– Location: September 26-27, 2023, New York, NY

2. 2023 Cell & Gene Meeting on the Mesa:

– Date: Wednesday, October 11, 2023
– Time: 11:00 AM PT
– Location: October 10-12, 2023, Carlsbad, CA

## Accessing Capsida’s Corporate Presentation

Investors and interested individuals can access the Capsida corporate presentation by visiting the presentations section on the company’s official website at www.capsida.com. The presentation will provide valuable insights into Capsida’s ongoing research, development, and strategic partnerships.

## About Capsida Biotherapeutics

Capsida Biotherapeutics is a groundbreaking gene therapy company focused on developing innovative treatments for both rare and common diseases across all age groups. Leveraging their proprietary adeno-associated virus (AAV)-based delivery technologies, Capsida is able to deliver a comprehensive range of therapeutic modalities, including DNA, RNA, gene editors, and vectorized antibodies, to specific organ systems. Importantly, their technology also minimizes exposure to non-targeted organs.

The company’s robust IP estate and capsid engineering expertise enable the identification and development of capsids with specific affinity for any tissue or cell type. Capsida’s initial focus is on delivering therapeutic cargoes intravenously to the central nervous system (CNS). Through their partnerships with industry leaders, such as AbbVie, Lilly, and CRISPR Therapeutics, Capsida is accelerating the development of innovative therapies for CNS disorders as well as ophthalmic disorders.

Capsida Biotherapeutics was founded in 2019 by lead investors Versant Ventures and Westlake Village BioPartners. The company originated from pioneering research conducted by Dr. Viviana Gradinaru, a renowned neuroscience professor at Caltech.

To learn more about Capsida Biotherapeutics and their innovative gene therapy solutions, visit their website at www.capsida.com.

# How AI legalese decoder Can Help

In complex legal documents and announcements like the one above, understanding the underlying information can be challenging for individuals who are not well-versed in legal terminology. This is where the AI legalese decoder can prove to be incredibly helpful.

The AI legalese decoder utilizes advanced natural language processing and machine learning algorithms to decipher legal documents and convert them into easily understandable language. By using this powerful tool, readers can gain a comprehensive understanding of the content without having to struggle through complicated jargon or technical terminology.

For example, the AI legalese decoder can simplify the description of Capsida Biotherapeutics by transforming intricate wording into straightforward explanations. This enables readers to grasp the company’s mission, technologies, and partnerships easily.

By employing the AI legalese decoder, individuals can save time, avoid confusion, and make informed decisions regarding investment opportunities, partnerships, or any legal matters associated with Capsida Biotherapeutics.

legal-document-to-plain-english-translator/”>Try Free Now: Legalese tool without registration

Find a LOCAL lawyer

Reference link